|4Jun 18, 9:24 PM ET

HealthQuest Partners II, L.P. 4

4 · Venus Concept Inc. · Filed Jun 18, 2020

Insider Transaction Report

Form 4
Period: 2020-06-16
Transactions
  • Conversion

    Common Stock

    2020-06-16+1,200,0005,195,612 total
  • Conversion

    Series A Preferred Stock

    2020-06-16120,0000 total
    From: 2020-06-16Common Stock (1,200,000 underlying)
Footnotes (3)
  • [F1]The shares of Series A Preferred Stock were originally purchased from the Issuer at a purchase price of $2.50 per unit (consisting of one-tenth of one share of Series A Preferred Stock and 0.75 of a Warrant, with each whole Warrant exercisable for one share of Common Stock, at an exercise price of $3.50 per share). Each share of Series A Preferred Stock converted into ten shares of Common Stock for no additional consideration.
  • [F2]The Series A Preferred Stock had no expiration date.
  • [F3]The shares are directly held by HealthQuest Partners II, L.P. ("HealthQuest"). HealthQuest Venture Management II, L.L.C. ("HQVM II"), the general partner of HealthQuest, and Garheng Kong, the managing member of HQVM II, may be deemed to have sole voting and dispositive power with respect to the shares held of record by HealthQuest. Mr. Kong and HQVM II disclaim beneficial ownership over all shares owned by HealthQuest except to the extent of any pecuniary interest therein.

Documents

1 file
  • 4
    tm2022985d1_form4.xmlPrimary

    FORM 4